📣 VC round data is live. Check it out!

SV Investment Valuation Multiples

Discover revenue and EBITDA valuation multiples for SV Investment and similar public comparables like Kinea Oportunidades Real Estate FII, Xlife Sciences, Creal, Triple Point Venture VCT and more.

SV Investment Overview

About SV Investment

SV Investment Corp operates as an Investment firm in South Korea. The company provides venture capital, initial public offer, merger and acquisition, operation consulting services and private equity investment services.


Founded

2006

HQ

South Korea

Employees

N/A

Sectors

Financials (FY)

Revenue: $14M
EBITDA: ($3M)

EV

$146M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

SV Investment Financials

SV Investment reported last fiscal year revenue of $14M and negative EBITDA of ($3M).

In the same fiscal year, SV Investment generated $8M in gross profit, ($3M) in EBITDA losses, and had net loss of ($4M).


SV Investment P&L

In the most recent fiscal year, SV Investment reported revenue of $14M and EBITDA of ($3M).

SV Investment is unprofitable as of last fiscal year, with gross margin of 59%, EBITDA margin of (24%), and net margin of (25%).

See analyst estimates for SV Investment
Last FY202320242025202620272028
Revenue$14M$19M$16M$14M
Gross Profit$8M$16M$10M$8M
Gross Margin59%81%66%59%
EBITDA($3M)$5M($1M)($3M)
EBITDA Margin(24%)24%(8%)(24%)
EBIT Margin(29%)21%(13%)(29%)
Net Profit($4M)$3M($2M)($4M)
Net Margin(25%)14%(12%)(25%)

Financial data powered by Morningstar, Inc.

SV Investment Stock Performance

SV Investment has current market cap of $138M, and enterprise value of $146M.


SV Investment's stock price is $2.53.

SV Investment has an EPS (earnings per share) of $-0.06.

See more trading valuation data for SV Investment
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$146M$138M0.2%$-0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

SV Investment Valuation Multiples

SV Investment trades at 10.3x EV/Revenue multiple, and (43.5x) EV/EBITDA.

See NTM and 2027E valuation multiples for SV Investment

SV Investment Financial Valuation Multiples

As of May 15, 2026, SV Investment has market cap of $138M and EV of $146M.

SV Investment has a P/E ratio of (39.2x).

Last FY202320242025202620272028
EV/Revenue10.3x7.6x9.3x10.3x
EV/EBITDA(43.5x)32.2x(112.7x)(43.5x)
EV/EBIT(35.9x)36.9x(73.4x)(35.9x)
EV/Gross Profit17.4x9.4x14.2x17.4x
P/E(39.2x)50.3x(71.8x)(39.2x)
EV/FCF(142.2x)(27.5x)(67.8x)(142.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified SV Investment Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

SV Investment Margins & Growth Rates

In the most recent fiscal year, SV Investment reported gross margin of 59%, EBITDA margin of (24%), and net margin of (25%).

See estimated margins and future growth rates for SV Investment

SV Investment Margins

Last FY20242025202720282029
Gross Margin59%66%59%
EBITDA Margin(24%)(8%)(24%)
EBIT Margin(29%)(13%)(29%)
Net Margin(25%)(12%)(25%)
FCF Margin(7%)(14%)(7%)

SV Investment Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(19%)(9%)
Gross Profit Growth(34%)(18%)
EBITDA Growth(129%)159%
EBIT Growth(150%)105%
Net Profit Growth(170%)83%
FCF Growth(59%)(52%)

Data powered by FactSet, Inc. and Morningstar, Inc.

SV Investment Operational KPIs

Access forward-looking KPIs for SV Investment
Last FY202320242025202620272028
S&M Expenses to Revenue11%9%10%11%
G&A Expenses to Revenue6%5%6%6%
Opex to Revenue88%60%78%88%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

SV Investment Competitors

SV Investment competitors include Kinea Oportunidades Real Estate FII, Xlife Sciences, Creal, Triple Point Venture VCT, Arbona, GalaxyEdge Acquisition, Rbr Log FII, DAOL Investment, Spectral Capital and Company K Partners.

Most SV Investment public comparables operate across PE & VC.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Kinea Oportunidades Real Estate FII4.2x
Xlife Sciences635.2x(57.3x)
Creal0.3x7.4x
Triple Point Venture VCT76.2x
Arbona0.9x5.6x
GalaxyEdge Acquisition(3457.3x)
Rbr Log FII7.3x7.2x
DAOL Investment5.7x

This data is available for Pro users. Sign up to see all SV Investment competitors and their valuation data.

Start Free Trial

SV Investment Investment Activity

SV Investment has invested in 69 companies to date.

Latest investment by SV Investment was on May 7th 2026. SV Investment invested in Caring in their $27M Series C round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by SV Investment

Caring
GenEdit
AITRICS
PineTree Therapeutics
Description
Caring runs visiting medical treatment facilities in South Korea, specializing in home-based consultations for chronic conditions and post-operative recovery. Physicians provide on-site assessments, medication management, and preventive health checkups tailored to elderly patients. Seoul-headquartered, the service integrates telemedicine options and collaborates with local hospitals for seamless referrals.
GenEdit is a South San Francisco-based biotechnology firm developing non-viral nanoparticle delivery systems for gene editing therapies. The NanoGalaxy platform screens billions of lipid nanoparticles to deliver CRISPR-Cas9 and other editors to specific tissues like liver, muscle, and brain. This approach addresses limitations of viral vectors by enabling safer, scalable production. Founded in 2017, GenEdit has raised over $50 million in funding and collaborates with Stanford University researchers. Its technology supports applications in genetic diseases such as muscular dystrophy and liver disorders.
PineTree Therapeutics is a biotechnology company developing therapies in oncology and immuno-oncology. Headquartered in Israel, it advances novel treatments targeting solid tumors using proprietary platforms for clinical trials in multiple indications.
HQ CountrySouth KoreaUnited StatesSouth KoreaUnited States
HQ City
Gangneung
San Francisco, CA
Deal Date7 May 202625 Feb 20261 Dec 202528 Oct 2025
RoundSeries CSeries BSeries CSeries B
Raised$27M$60M$24M$47M
InvestorsHyundai Investment Partners; IMM Investment; STIC Investments; STIC Ventures; SV InvestmentACVC Partners; Dayli Partners; DSC Investment; Kiwoom Investment; Korea Investment Partners; loftyrock investment; Pathway Investment; STIC Ventures; SV Investment; Top Harvest Capital; Woori Venture Partners; Yuanta InvestmentBSK Investment; Han River Partners; Mirae Asset Capital; Mirae Asset Venture Investment; Premier Partners; Solidus Investment; SV InvestmentAtinum Investment; DSC Investment; Gauss Capital Management; Korea Investment Partners; S&S Investment; SGI Venture Capital; SJ Investment Partners; Smilegate Investment; STIC Ventures; SV Investment; Widwin Investment
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all SV Investment investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About SV Investment

When was SV Investment founded?SV Investment was founded in 2006.
Where is SV Investment headquartered?SV Investment is headquartered in South Korea.
Is SV Investment publicly listed?Yes, SV Investment is a public company listed on Korea Exchange.
What is the stock symbol of SV Investment?SV Investment trades under 289080 ticker.
When did SV Investment go public?SV Investment went public in 2018.
Who are competitors of SV Investment?SV Investment main competitors include Kinea Oportunidades Real Estate FII, Xlife Sciences, Creal, Triple Point Venture VCT, Arbona, GalaxyEdge Acquisition, Rbr Log FII, DAOL Investment, Spectral Capital, Company K Partners.
What is the current market cap of SV Investment?SV Investment's current market cap is $138M.
What is the current revenue of SV Investment?SV Investment's last fiscal year revenue is $14M.
What is the current EV/Revenue multiple of SV Investment?Current revenue multiple of SV Investment is 10.3x.
Is SV Investment profitable?No, SV Investment is not profitable.
How many companies SV Investment has acquired to date?SV Investment hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies SV Investment has invested to date?As of May 2026, SV Investment has invested in 69 companies.
What was the last SV Investment investment?On 7th May 2026 SV Investment invested in Caring, participating in a $27M Series C round, alongside Hyundai Investment Partners, IMM Investment, STIC Investments, and STIC Ventures.
In what companies SV Investment invested in?SV Investment invested in GenEdit, MyRealTrip, Amogy, ABLY Corporation, SemiFive, PineTree Therapeutics, XCENA, SM Lab, Maka Motors, Caring, Newracle Genetics, 3i, AITRICS, Above Golf Link, AGL, Swit, Innospace, Catch Fashion, Nextchip Co, Vedanta Biosciences, and 49 other companies.

See public comps similar to SV Investment

Lists including SV Investment

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial